Biolidics' Covid-19 rapid test kit allowed to be sold in EU

Singapore

SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).

This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.